Enova (NYSE: ENVA) chair receives new RSU and option grants

Rhea-AI Filing Summary

Enova International Executive Chairman David Fisher received new equity awards in the form of common stock and stock options. On February 11, 2026, he was granted 13,515 shares of common stock as restricted stock units at a price of $0 per share, increasing his directly owned common stock to 333,587 shares.

He was also granted 8,684 non-qualified stock options with a limited stock appreciation right at an exercise price of $157.79 per share, leaving him with 8,684 such options outstanding. The 13,515 restricted stock units vest in four equal annual installments from February 11, 2027 through February 11, 2030, while the options vest in three equal annual installments from February 11, 2027 through February 11, 2029.

Insider Trade Summary

2 transactions reported

Mixed 2 txns

Insider Fisher David

Role Executive Chairman

Type	Security	Shares	Price	Value
Grant/Award	Non-Qualified Stock Option (right to buy) with limited SAR	8,684	$0.00	--
Grant/Award	Common stock, par value $0.00001 per share	13,515	$0.00	--

Holdings After Transaction: Non-Qualified Stock Option (right to buy) with limited SAR — 8,684 shares (Direct); Common stock, par value $0.00001 per share — 333,587 shares (Direct)

Footnotes (1)

1. This transaction reflects a grant of restricted stock units that shall vest in substantially equal one-fourth increments on each of the following dates as long as grantee serves as an employee of the Issuer or an affiliate thereof through the applicable vesting date: February 11, 2027, February 11, 2028, February 11, 2029 and February 11, 2030. The limited stock appreciation right ("SAR") and employee stock option were granted in tandem. Accordingly, the exercise of one results in the expiration of the other. The SAR may be exercised only during the period beginning on the first day following the date that a "Change in Control" of Issuer occurs (as defined in the related grant agreement) and ending on the thirtieth day following such date. Upon exercise, the grantee shall be able to receive an amount equal to the product computed by multiplying (i) the excess of the "Offer Value Per Share" over the exercise price of the underlying option by (ii) the number of shares with respect to which the SAR is being exercised; provided, that such amount shall only be payable in the event an "Offer" is made. The "Offer Value Per Share" means the average selling price of Issuer's common stock during the period of 30 days ending on the date on which the SAR is exercised. "Offer" means any tender offer or exchange offer for outstanding shares of Issuer representing at least 30% of the total voting power of the stock of Issuer, or an offer to purchase assets from Issuer that have a total gross fair market value equal to or more than 40% of the total gross fair market value of all of the assets of Issuer, other than an offer made by Issuer. The options shall vest in substantially equal one-third increments on each of the following dates as long as grantee serves as an employee of Issuer or an affiliate thereof through the applicable vesting date: February 11, 2027, February 11, 2028 and February 11, 2029.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Fisher David

(Last) (First) (Middle)

C/O ENOVA INTERNATIONAL, INC.

175 W. JACKSON BOULEVARD, SUITE 600

(Street)

CHICAGO IL 60604

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Enova International, Inc. [ ENVA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Executive Chairman

3. Date of Earliest Transaction (Month/Day/Year)
02/11/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common stock, par value $0.00001 per share	02/11/2026		A		13,515(1)	A	$0	333,587	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Non-Qualified Stock Option (right to buy) with limited SAR(2)(3)	$157.79	02/11/2026		A		8,684		(4)	02/11/2033	Common stock; par value $0.00001 per share	8,684	$0	8,684	D

Explanation of Responses:

1. This transaction reflects a grant of restricted stock units that shall vest in substantially equal one-fourth increments on each of the following dates as long as grantee serves as an employee of the Issuer or an affiliate thereof through the applicable vesting date: February 11, 2027, February 11, 2028, February 11, 2029 and February 11, 2030.

2. The limited stock appreciation right ("SAR") and employee stock option were granted in tandem. Accordingly, the exercise of one results in the expiration of the other. The SAR may be exercised only during the period beginning on the first day following the date that a "Change in Control" of Issuer occurs (as defined in the related grant agreement) and ending on the thirtieth day following such date. Upon exercise, the grantee shall be able to receive an amount equal to the product computed by multiplying (i) the excess of the "Offer Value Per Share" over the exercise price of the underlying option by (ii) the number of shares with respect to which the SAR is being exercised; provided, that such amount shall only be payable in the event an "Offer" is made.

3. The "Offer Value Per Share" means the average selling price of Issuer's common stock during the period of 30 days ending on the date on which the SAR is exercised. "Offer" means any tender offer or exchange offer for outstanding shares of Issuer representing at least 30% of the total voting power of the stock of Issuer, or an offer to purchase assets from Issuer that have a total gross fair market value equal to or more than 40% of the total gross fair market value of all of the assets of Issuer, other than an offer made by Issuer.

4. The options shall vest in substantially equal one-third increments on each of the following dates as long as grantee serves as an employee of Issuer or an affiliate thereof through the applicable vesting date: February 11, 2027, February 11, 2028 and February 11, 2029.

	/s/ Sean Rahilly, as attorney in fact	02/13/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What equity awards did Enova (ENVA) Executive Chairman David Fisher receive?

David Fisher received 13,515 restricted stock units and 8,684 non-qualified stock options. The stock was granted at $0 per share and the options have a $157.79 exercise price, reflecting equity-based compensation rather than open-market buying.

How do David Fisher’s new restricted stock units at Enova (ENVA) vest?

The 13,515 restricted stock units vest in four substantially equal installments. Vesting dates are February 11, 2027, February 11, 2028, February 11, 2029, and February 11, 2030, and require Fisher to remain an employee through each applicable vesting date.

What are the terms of David Fisher’s new Enova (ENVA) stock options?

Fisher received 8,684 non-qualified stock options with an exercise price of $157.79 per share. These options vest in three substantially equal annual installments on February 11, 2027, February 11, 2028, and February 11, 2029, contingent on continued employment.

What is the limited stock appreciation right attached to David Fisher’s Enova options?

The stock appreciation right is paired with the employee stock option, so exercising one cancels the other. It becomes exercisable only after a defined Change in Control and provides cash based on the Offer Value Per Share above the option exercise price, if a qualifying offer occurs.

How many Enova (ENVA) shares does David Fisher own after these grants?

Following the reported restricted stock unit grant, Fisher beneficially owns 333,587 shares of Enova common stock directly. He also holds 8,684 non-qualified stock options, giving him additional potential equity exposure subject to vesting and exercise conditions described in the award terms.

Is David Fisher’s Form 4 transaction a stock purchase or a compensation grant?

The Form 4 shows compensation grants, not open-market purchases. Both the 13,515 restricted stock units and the 8,684 options were acquired at a reported price of $0 per share, consistent with equity awards rather than buying shares on the market.